The effect of whole-body electromyostimulation on metabolic syndrome in affected adults: A subanalysis of a randomized controlled trial

Many people with osteoarthritis of the knee suffer from overweight, obesity, and cardiometabolic conditions. In the present subanalysis of a randomized controlled trial of the effect of whole-body electromyostimulation (WB-EMS) on knee osteoarthritis in overweight Caucasians, we focus on participants with Metabolic Syndrome (MetS). Based on previous research, we hypothesized that WB-EMS significantly improves the Metabolic Syndrome <i>Z</i> score (MetS-Z score) compared with non-training controls. Thirty-two of the initial 72 overweight adults (58 ± 6 years, body mass index: 31 ± 4 kg/m<sup>2</sup>) with knee osteoarthritis, randomly allocated to a 29-week standard WB-EMS application or to a non-exercising control group (CG) and suffering from MetS, were included. The primary outcome was the MetS-Z score, based on the criteria of the International Diabetes Federation. Secondary outcomes were MetS components, i.e., waist circumference, mean arterial blood pressure, fasting glucose, triglycerides, and HDL-cholesterol. Based on the intention-to-treat principle, analysis of covariance determines differences between the groups (i.e., "effects"). In total, three participants were lost to 29-week follow-up. The attendance rate averaged 89% ± 9% in the WB-EMS group. Adverse effects related to the intervention were not observed. WB-EMS (<i>n</i> = 17) induced a non-significant, medium-size effect (<i>p</i> = 0.061; <i>η</i> <sup>2</sup> = 0.13) on the MetS-Z score compared with non-exercise CG (<i>n</i> = 15). In addition, no significant effects (<i>p</i> ≥ 0.146) were observed for MetS components. In the present study, we observed a moderate, although non-significant effect on the MetS-Z score. Given that the WB-EMS application was well-tolerated and accepted by the participants, we conclude that this exercise technology may offer (limited) benefits for MetS treatment. Nevertheless, further studies should address this issue with higher statistical power.

Authors

Institutions

Publication Details

Journal
Frontiers in Sports and Active Living
Published
2025-07-01
DOI
https://doi.org/10.3389/fspor.2025.1585579
Primary Topic
Muscle activation and electromyography studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effect of whole-body electromyostimulation on metabolic syndrome in affected adults: A subanalysis of a randomized controlled trial

WOLFGANG K. KEMMLER, Simon von Stengel, Stephanie Kast, Frank W. Roemer et al.
1 links
Frontiers in Sports and Active Living
Muscle activation and electromyography studies
article

The effect of whole-body electromyostimulation on metabolic syndrome in affected adults: A subanalysis of a randomized controlled trial

WOLFGANG K. KEMMLER, Simon von Stengel, Stephanie Kast, Frank W. Roemer, Matthias Kohl, Michael Uder, Leon Mendel
article en

Abstract

Many people with osteoarthritis of the knee suffer from overweight, obesity, and cardiometabolic conditions. In the present subanalysis of a randomized controlled trial of the effect of whole-body electromyostimulation (WB-EMS) on knee osteoarthritis in overweight Caucasians, we focus on participants with Metabolic Syndrome (MetS). Based on previous research, we hypothesized that WB-EMS significantly improves the Metabolic Syndrome <i>Z</i> score (MetS-Z score) compared with non-training controls. Thirty-two of the initial 72 overweight adults (58 ± 6 years, body mass index: 31 ± 4 kg/m<sup>2</sup>) with knee osteoarthritis, randomly allocated to a 29-week standard WB-EMS application or to a non-exercising control group (CG) and suffering from MetS, were included. The primary outcome was the MetS-Z score, based on the criteria of the International Diabetes Federation. Secondary outcomes were MetS components, i.e., waist circumference, mean arterial blood pressure, fasting glucose, triglycerides, and HDL-cholesterol. Based on the intention-to-treat principle, analysis of covariance determines differences between the groups (i.e., "effects"). In total, three participants were lost to 29-week follow-up. The attendance rate averaged 89% ± 9% in the WB-EMS group. Adverse effects related to the intervention were not observed. WB-EMS (<i>n</i> = 17) induced a non-significant, medium-size effect (<i>p</i> = 0.061; <i>η</i> <sup>2</sup> = 0.13) on the MetS-Z score compared with non-exercise CG (<i>n</i> = 15). In addition, no significant effects (<i>p</i> ≥ 0.146) were observed for MetS components. In the present study, we observed a moderate, although non-significant effect on the MetS-Z score. Given that the WB-EMS application was well-tolerated and accepted by the participants, we conclude that this exercise technology may offer (limited) benefits for MetS treatment. Nevertheless, further studies should address this issue with higher statistical power.

Frontiers in Sports and Active LivingVol. 7
Boston University (US), Universitätsklinikum Erlangen (DE), Furtwangen University (DE)
Else Kröner-Fresenius-Stiftung
Good health and well-being
Openalex Percentile: Top 85%
Muscle activation and electromyography studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.